Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-12-17

Clinical Trial Update: Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy and tolerability of fractional ablative Erbium laser for axillary scarring in hidradenitis suppurativa patients has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Montefiore Medical Center | Conditions: Hidradenitis Suppurativa, Scarring | NA | Status: WITHDRAWN